Back to search

Article

Blood-based protein biomarkers in definite frontotemporal dementia: a case-control study

2022-05-05

Abstract excerpt

<title>Abstract</title> <p>Background: Frontotemporal dementia (FTD) is caused by frontotemporal lobar degeneration (FTLD), characterized mainly by inclusions of Tau (FTLD-Tau) or TAR DNA binding43 (FTLD-TDP) proteins. Plasma biomarkers are strongly needed for specific diagnosis and potential treatment monitoring of FTD. We aimed to identify specific FTD plasma biomarker profiles discriminating FTD from AD and co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d408f4d9-72d6-597e-b297-75ad95775ce5
DOI
10.21203/rs.3.rs-1534214/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Blood-based protein biomarkers in definite frontotemporal dementia: a case-control studyDOI 10.21203/rs.3.rs-1534214/v1
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosisSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity
The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of ProteomicsSemantic proximity
Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.Semantic proximity
Altered plasma protein profiles in genetic FTD - a GENFI study.Semantic proximity
Plasma vs. serum: which is better for proteomic blood biomarker analysis? Evaluation of the novel NULISA platformSemantic proximity
Deep Plasma Proteomics Reveals Shared and Disease-Specific Molecular Signatures in Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity
Identification of Novel Biomarkers for Alzheimer’s Disease and Related Dementias Using Unbiased Plasma ProteomicsSemantic proximity
Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSFSemantic proximity
Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental ValidationSemantic proximity
High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity
Proteome-wide association study identifies novel Alzheimer's disease- associated proteinsSemantic proximity
Select a neighboring publication to make it the new centre.